Works matching DE "NEUTROPENIA"

Results: 4533

Association of Neutropenia With Valganciclovir Prophylaxis Dosing Practices Within Pediatric Solid Organ Transplant Recipients.

Published in:

Pediatric Transplantation, 2025, v. 29, n. 4, p. 1, doi. 10.1111/petr.70098

By:

Gerthoffer, Emma;
Pozderac, Amber;
Darland, Leanna;
Yasechko, Stephanie;
Crooker, Anna;
Hambrick, H. Rhodes;
Danziger‐Isakov, Lara

Publication type:

Article

3 Things You Should Know About Advances in CLL Management.

Published in:

Oncology (08909091), 2025, v. 39, n. 4, p. 164

By:

Brown, Jennifer R.;
Danilov, Alexey V.;
Davids, Matthew S.

Publication type:

Article

The Neutropenic Diet... Still Ageless?

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 586

By:

AFTANDILIAN, CATHERINE C.;
MILOTICH, CASEY;
SAKAMOTO, KATHLEEN M.

Publication type:

Article

Eat Your Vegetables.

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 385

By:

GARDNER, ALISON E.

Publication type:

Article

The Neutropenic Diet Reviewed: Moving Toward a Safe Food Handling Approach.

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 572

By:

FOX, NICOLE;
FREIFELD, ALISON G.

Publication type:

Article

When to Treat Myelodysplastic Syndromes.

Published in:

Oncology (08909091), 2011, v. 25, n. 6, p. 480

By:

AKHTARI, MOJTABA

Publication type:

Article

What Is the Role of Maintenance Rituximab in Follicular NHL?

Published in:

Oncology (08909091), 2008, v. 22, n. 1, p. 20

By:

Maloney, David G.

Publication type:

Article

Irinotecan-Induced Neutropenia and UGT1A1 *28: Does Dose Matter?

Published in:: 2007
Publication type:: Abstract

Management of Chemotherapy-Induced Neutropenia in the Older Cancer Patient.

Published in:

Oncology (08909091), 2006, v. 20, p. 26

By:

Balducci, Lodovico

Publication type:

Article

First-Cycle CSF Use in Breast Cancer and NHL: Guidelines and Recommendations.

Published in:

Oncology (08909091), 2006, v. 20, p. 7

By:

Al-Kali, Aref;
Ozer, Howard

Publication type:

Article

Advances in the Management of Chemotherapy-Induced Neutropenia.

Published in:

Oncology (08909091), 2006, v. 20, p. 4

By:

Crawford, Jeffrey

Publication type:

Article

Myeloid Growth Factor Support for Dose-Dense Adjuvant Chemotherapy for Breast Cancer.

Published in:

Oncology (08909091), 2006, v. 20, p. 13

By:

Burstein, Harold J.

Publication type:

Article

Risk Assessment and Guidelines for First-Cycle Colony-Stimulating Factor Use in the Management of Chemotherapy-Induced Neutropenia.

Published in:

Oncology (08909091), 2006, v. 20, p. 22

By:

Crawford, Jeffrey

Publication type:

Article

Granulocyte Colony-Stimulating Factor Use in Patients With Chemotherapy-Induced Neutropenia: Clinical and Economic Benefits.

Published in:

Oncology (08909091), 2006, v. 20, p. 16

By:

Rader, Michael

Publication type:

Article

The Timing of Chemotherapy-Induced Neutropenia and Its Clinical and Economic Impact.

Published in:

Oncology (08909091), 2006, v. 20, p. 11

By:

Ozer, Howard

Publication type:

Article

Colony-Stimulating Factor Use in the Context of Refined Risk and Benefit Assessments.

Published in:

Oncology (08909091), 2006, v. 20, p. 9

By:

Crawford, Jeffrey

Publication type:

Article

ASH Highlights in Neutropenia.

Published in:: 2006
Publication type:: Abstract

Neutropenia in the Breast Cancer Patient.

Published in:: 2006
Publication type:: Abstract

Role of Myeloid Growth Factors.

Published in:: 2006
Publication type:: Abstract

Developing Policies and Guidelines for Patients With Neutropenia.

Published in:: 2006
Publication type:: Abstract

Consequences of Febrile Neutropenia.

Published in:: 2006
Publication type:: Abstract

Introduction: The Impact of Neutropenia and Myeloid Growth Factors on Cancer Management.

Published in:

Oncology (08909091), 2006, v. 20, p. 11

By:

Crawford, Jeffrey

Publication type:

Article

Neutropenia: Defining Patient Risks.

Published in:: 2006
Publication type:: Abstract

Neutropenia and Thrombocytopenia Induced By Quetiapine Monotherapy: A Case Report and Review of Literature.

Published in:

Klinik Psikofarmakoloji Bulteni, 2016, v. 26, n. 3, p. 319, doi. 10.5455/bcp.20151219072235

By:

Arslan, Filiz Civil;
Aykut, Demet Saglam;
Ince, Canan;
Tiryaki, Ahmet

Publication type:

Article

Can lithium routinely used for the treatment of antipsychotics-induced neutropenia?

Published in:

2013

By:

Akbaba, Nursel;
Annagur, Bilge Burcak

Publication type:

Abstract

Renal Paratransplant Hernia: An Iatrogenic Surgical Emergency.

Published in:

Indian Journal of Surgery, 2024, v. 86, n. 2, p. 451, doi. 10.1007/s12262-023-03826-9

By:

Singh, Pradeep;
Ray, Deepak Shankar;
Narayan, Pradeep;
Dubey, Sanjay Kumar

Publication type:

Article

Gentle Chemotherapy in Breast Cancer.

Published in:

Indian Journal of Surgery, 2022, v. 84, p. 647, doi. 10.1007/s12262-020-02557-5

By:

Sood, Anukriti;
Ranjan, Piyush;
Gogia, Ajay;
Srivastava, Anurag;
Dhar, Anita;
Kataria, Kamal;
Mathur, Sandeep

Publication type:

Article

Autologous stem cell transplant in adult multiple sclerosis patients: A study from North India.

Published in:

2020

By:

Dayama, Aniruddha;
Bhargava, Rahul;
Kurmi, Santosh;
Jain, Sachin;
Dua, Vikas;
Kurmi, Santosh R

Publication type:

journal article

Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration.

Published in:

Veterinary & Comparative Oncology, 2024, v. 22, n. 4, p. 613, doi. 10.1111/vco.13015

By:

Thomas, Albert;
Finlay, Jessica;
McKinnon, Elizabeth;
Wyatt, Ken

Publication type:

Article

Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience.

Published in:

Veterinary & Comparative Oncology, 2024, v. 22, n. 4, p. 542, doi. 10.1111/vco.13004

By:

Busser, Suzanne;
Blackwood, Laura;
Pereira, Constanza;
Chase‐Topping, Margo;
Bavcar, Spela;
Fournier, Quentin

Publication type:

Article

Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 3, p. 577, doi. 10.1111/vco.12809

By:

Treggiari, Elisabetta;
Cossu, Giovanna;
Valenti, Paola;
Taylor, Angela

Publication type:

Article

Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 147, doi. 10.1111/vco.12455

By:

Wittenburg, Luke A.;
Weishaar, Kristen;
Ramirez, Dominique;
Gustafson, Daniel L.

Publication type:

Article

Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E52, doi. 10.1111/vco.12332

By:

Wouda, R. M.;
Hocker, S. E.;
Higginbotham, M. L.

Publication type:

Article

Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 919, doi. 10.1111/vco.12232

By:

Pellin, M. A.;
Wouda, R. M.;
Robinson, K.;
Tsimbas, K.;
Kurzman, I. D.;
Biller, B. J.;
Vail, D. M.

Publication type:

Article

Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 3, p. 710, doi. 10.1111/vco.12211

By:

Merrick, C. H.;
Pierro, J.;
Schleis, S. E.;
Sones, E. A.;
Wright, Z. M.;
Regan, R. C.;
Siedlecki, C. T.;
Bergman, P. J.

Publication type:

Article

Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 400, doi. 10.1111/vco.12176

By:

Gillem, J.;
Giuffrida, M.;
Krick, E.

Publication type:

Article

Nucleated erythrocytes in blood smears of dogs undergoing chemotherapy.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 1, p. 215, doi. 10.1111/vco.12156

By:

Moretti, P.;
Giordano, A.;
Stefanello, D.;
Ferrari, R.;
Castellano, S.;
Paltrinieri, S.

Publication type:

Article

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia<sup>®</sup>) in tumour-bearing dogs: a phase I dose-finding study.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 2, p. 202, doi. 10.1111/vco.12091

By:

Pan, X.;
Tsimbas, K.;
Kurzman, I. D.;
Vail, D. M.

Publication type:

Article

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 174, doi. 10.1111/j.1476-5829.2011.00261.x

By:

Robat, C.;
London, C.;
Bunting, L.;
McCartan, L.;
Stingle, N.;
Selting, K.;
Kurzman, I.;
Vail, D. M.

Publication type:

Article

Comparison between -CHOP and an -CHOP protocol with interposed treatments of CCNU and MOPP (-CHOP-CCNU-MOPP) for lymphoma in dogs K. M. Rassnick et al.

Published in:

Veterinary & Comparative Oncology, 2010, v. 8, n. 4, p. 243, doi. 10.1111/j.1476-5829.2010.00224.x

By:

Rassnick, K. M.;
Bailey, D. B.;
Malone, E. K.;
Intile, J. L.;
Kiselow, M. A.;
Flory, A. B.;
Barlow, L. L.;
Balkman, C. E.;
Barnard, S. M.;
Waite, A. H.

Publication type:

Article

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.

Published in:

Veterinary & Comparative Oncology, 2010, v. 8, n. 2, p. 138, doi. 10.1111/j.1476-5829.2010.00217.x

By:

Rassnick, K. M.;
Bailey, D. B.;
Russell, D. S.;
Flory, A. B.;
Kiselow, M. A.;
Intile, J. L.;
Malone, E. K.;
Balkman, C. E.;
Barnard, S. M.

Publication type:

Article

Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs.

Published in:

Veterinary & Comparative Oncology, 2009, v. 7, n. 1, p. 69, doi. 10.1111/j.1476-5829.2008.00175.x

By:

Intile, J. L.;
Rassnick, K. M.;
Bailey, D. B.;
Al-Sarraf, R.;
Chretin, J. D.;
Balkman, C. E.;
Flory, A. B.;
Kiselow, M. A.;
Wakshlag, J. J.

Publication type:

Article

Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin.

Published in:

Veterinary & Comparative Oncology, 2003, v. 1, n. 4, p. 171, doi. 10.1111/j.1476-5810.2003.00024.x

By:

Payne, S. E.;
Rassnick, K. M.;
Northrup, N. C.;
Kristal, O.;
Chretin, J. D.;
Cotter, S. M.;
Kintzer, P.;
Frimberger, A. E.;
Morrison-Collister, K. E.;
Wood, C. A.;
Moore, A. S.

Publication type:

Article

Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.

Published in:

International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 96, doi. 10.1007/s10147-011-0349-5

By:

Yano, Ryoichi;
Konno, Aya;
Watanabe, Kyohei;
Tsukamoto, Hitoshi;
Kayano, Yuichiro;
Ohnaka, Hiroaki;
Goto, Nobuyuki;
Nakamura, Toshiaki;
Masada, Mikio

Publication type:

Article

Catheter-related bloodstream infection with removal of catheter in pediatric oncology patients: a 10-year experience in Taiwan.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 124, doi. 10.1007/s10147-011-0268-5

By:

Chen, Shih-Hsiang;
Yang, Chao-Ping;
Jaing, Tang-Her;
Lai, Jin-Yao;
Hung, Iou-Jih

Publication type:

Article

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 150, doi. 10.1007/s10147-011-0272-9

By:

Kambe, Mariko;
Kikuchi, Hiroaki;
Gamo, Makio;
Yoshioka, Takashi;
Ohashi, Yasuo;
Kanamaru, Ryunosuke

Publication type:

Article

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 5, p. 468, doi. 10.1007/s10147-010-0094-1

By:

Watanabe, Yoh;
Etoh, Tomomaro;
Koike, Eiji;
Mizuno, Yoshiaki;
Wang, Wei-Min;
Hoshiai, Hiroshi

Publication type:

Article

A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 5, p. 476, doi. 10.1007/s10147-010-0099-9

By:

Hongo, Atsushi;
Kusumoto, Tomoyuki;
Nakamura, Keiichiro;
Seki, Noriko;
Kodama, Junichi;
Hiramatsu, Yuji

Publication type:

Article

Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 4, p. 369, doi. 10.1007/s10147-010-0069-2

By:

Tanji, Nozomu;
Ozawa, Akira;
Miura, Noriyoshi;
Yanagihara, Yutaka;
Sasaki, Toyokazu;
Nishida, Takayasu;
Kikugawa, Tadahiko;
Ikeda, Tetsuhiro;
Ochi, Tatsumasa;
Shimamoto, Kenji;
Aoki, Katsunori;
Yokoyama, Masayoshi

Publication type:

Article

The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 2, p. 172, doi. 10.1007/s10147-010-0039-8

By:

Ohno, Hitoshi;
Mizumoto, Chisaki;
Otsuki, Yoshihiro;
Oguma, Shigeru;
Yoshida, Yataro

Publication type:

Article